GLYMAB
Live / Registered — Registered (as of 27 Jun 2023)
What this means for you
Registered since 27 Jun 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97289101
- Registration number
- 7090280
- Mark type
- Stylized text
- Filed
- 01 Mar 2022
- Published for opposition
- 11 Apr 2023
- Registered
- 27 Jun 2023
- Attorney of record
- Andrew D. Price
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, therapeutic and medicinal preparations and substances to increase the avidity of antibodies for the treatment of cancer; all the foregoing containing monoclonal antibodies; pharmaceutical compounds for the treatment of cancer, all the foregoing containing monoclonal antibodies
Owner
- Scancell Limited, Oxford, GB
- Scancell Limited, Oxford, GB
- Scancell Limited, Oxford, GB
Prosecution history
- 27 Jun 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jun 2023 — REGISTERED-PRINCIPAL REGISTER
- 11 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Apr 2023 — PUBLISHED FOR OPPOSITION
- 22 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Mar 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Dec 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 13 Dec 2022 — NON-FINAL ACTION E-MAILED
- 13 Dec 2022 — NON-FINAL ACTION WRITTEN
- 13 Dec 2022 — ASSIGNED TO EXAMINER
- 11 Mar 2022 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 10 Mar 2022 — ASSIGNED TO LIE